Emil Iii Frei
#96,545
Most Influential Person Now
Emil Iii Frei's AcademicInfluence.com Rankings
Emil Iii Freiphilosophy Degrees
Philosophy
#3672
World Rank
#5888
Historical Rank
Logic
#1319
World Rank
#2040
Historical Rank
Download Badge
Philosophy
Why Is Emil Iii Frei Influential?
(Suggest an Edit or Addition)Emil Iii Frei's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. (1994) (1379)
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide (1960) (1034)
- Dose: a critical factor in cancer chemotherapy. (1980) (831)
- A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. (1978) (514)
- Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. (1980) (450)
- Holland-Frei Cancer Medicine (2016) (361)
- Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. (1988) (334)
- Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. (1990) (331)
- Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. (1975) (322)
- Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). (1987) (321)
- The Effect of 6-Mercaptopurine on the Duration of Steroid-induced Remissions in Acute Leukemia: A Model for Evaluation of Other Potentially Useful Therapy (1963) (290)
- THE DISTRIBUTION OF THE PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA. (1963) (272)
- The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. (1965) (261)
- Clinical trials with adriamycin (1971) (244)
- Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. (1988) (240)
- Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). (1969) (240)
- New approaches to cancer chemotherapy with methotrexate. (1975) (227)
- Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. (1974) (225)
- Active immunotherapy with B.C.G. for recurrent malignant melanoma. (1973) (223)
- Treatment of acute myelogenous leukemia in children and adults. (1980) (220)
- Studies of Sequential and Combination Antimetabolite Therapy in Acute Leukemia: 6-Mercaptopurine and Methotrexate (1961) (206)
- Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide (1972) (204)
- Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. (1983) (201)
- Curative cancer chemotherapy. (1985) (181)
- Combination cancer therapy: Presidential address. (1972) (179)
- RESPONSE TO REPEATED PLATELET TRANSFUSION FROM THE SAME DONOR. (1963) (177)
- Progress and perspectives in the chemotherapy of acute leukemia. (1965) (171)
- Osteosarcoma: fifteen years later. (1985) (170)
- L-dopa: selective toxicity for melanoma cells in vitro. (1977) (166)
- Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. (1986) (163)
- A comparative study of two regimens of combination chemotherapy in acute leukemia. (1958) (155)
- Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission. (1973) (152)
- Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts (1975) (150)
- Alkylating agent resistance: in vitro studies with human cell lines. (1985) (147)
- Pseudomonas septicemia; observations on twenty-three cases. (1958) (139)
- The effect of chemotherapy on acute leukemia in the human. (1961) (133)
- Clinical studies with vincristine. (1963) (132)
- URIC ACID EXCRETION AND RENAL FUNCTION IN THE ACUTE HYPERURICEMIA OF LEUKEMIA. PATHOGENESIS AND THERAPY OF URIC ACID NEPHROPATHY. (1964) (131)
- The Stathmokinetic Effect of Vincristine (1964) (131)
- Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results. (1978) (128)
- Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts. (1976) (120)
- IMMUNOLOGIC AND CYTOGENETIC STUDIES OF CHRONIC LYMPHOCYTIC LEUKEMIC CELLS. (1965) (119)
- Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia (1971) (114)
- Prognostic significance of pretreatment proliferative activity in adult acute leukemia (1977) (113)
- The prevention of methotrexate toxicity by thymidine infusions in humans. (1977) (105)
- Cell proliferation in human melanoma. (1970) (100)
- Chemotherapy of malignant lymphoma with adriamycin. (1973) (98)
- The Philadelphia chromosome and chronic myelogenous leukemia. (1966) (93)
- Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts. (1980) (93)
- Clinical studies of fever and infection in cancer (1960) (92)
- The Transfusion of Leukocytes from Donors with Chronic Myelocytic Leukemia to Patients with Leukopenia * (1966) (90)
- Pharmacokinetics of actinomycin 0 in patients with malignant melanoma (1975) (89)
- Infection and Immunity in Chronic Lymphocytic Leukemia (1960) (87)
- The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects (1975) (87)
- Cytogenetic studies and their clinical correlates in adults with acute leukemia. (1971) (87)
- RENAL COMPLICATIONS OF NEOPLASTIC DISEASE. (1963) (87)
- Intensive combination chemotherapy and X-irradiation in Hodgkin's disease. (2016) (87)
- THE EFFECT OF 6-MERCAPTOPURINE ON IMMUNE RESPONSE IN MAN. (1964) (86)
- Fever, infection and host resistance in acute leukemia. (1958) (85)
- The nature and control of infections in patients with acute leukemia. (1965) (83)
- The association of fatal intracranial hemorrhage and blastic crisis in patients with acute leukemia. (1959) (83)
- Quantitative studies of human leukocytic and febrile response to single and repeated doses of purified bacterial endotoxin. (1962) (82)
- The chemotherapy of human and animal acute leukemia. (1971) (76)
- Studies of a patient isolator unit and prophylactic antibiotics in cancer chemotherapy. General techniques and preliminary results (1968) (74)
- Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial. (1980) (73)
- Thymidine rescue of high-dose methotrexate in humans. (1978) (72)
- Persistent Mitosis of Transfused Homologous Leukocytes in Children Receiving Antileukemic Therapy (1963) (71)
- Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo. (1989) (69)
- A PRELIMINARY REPORT ON VINCRISTINE SULFATE—A NEW ACTIVE AGENT FOR THE TREATMENT OF ACUTE LEUKEMIA (1962) (65)
- A controlled trial of urethane treatment in multiple myeloma. (1966) (65)
- The National Cancer Chemotherapy Program. (1982) (65)
- L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrow. (1970) (63)
- Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture. (1984) (62)
- High-dose thymidine infusions in patients with leukemia and lymphoma. (1980) (62)
- Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo. (1988) (62)
- The role of vincristine in the treatment of childhood acute leukemia (1966) (61)
- Approaches to improving the chemotherapy of Hodgkin's disease. (1966) (60)
- Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts. (1975) (59)
- A Study of Prednisone Therapy in Chronic Lymphocytic Leukemia (1961) (59)
- COMPARISON OF THREE METHODS OF CENTRAL-NERVOUS-SYSTEM PROPHYLAXIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKÆMIA (1980) (56)
- The role of intensive postinduction chemotherapy in the management of patients with acute myelogenous leukemia. (1982) (56)
- Clostridial gas gangrene and septicemia in four patients with leukemia. (1958) (54)
- Comparative chemotherapy of AKR lymphoma and human hematological neoplasia. (1974) (53)
- Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramide. (1989) (52)
- Pharmacologic studies of the antitumor agent 5-(dimethyltriazeno)imidazole-4-carboxamide. (1968) (52)
- Role of murine tumor models in cancer treatment research. (1986) (51)
- Methylglyoxal bis (guanylhydrazone): a new agent active against acute myelocytic leukemia. (1962) (51)
- Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy. (1976) (48)
- Principles of Medical Oncology (2003) (47)
- THE EFFECT OF SKIN HOMOGRAFT REJECTION ON RECIPIENT AND DONOR MIXED LEUKOCYTE CULTURES (1965) (47)
- Selective expansion of 5,10-methylenetetrahydrofolate pools and modulation of 5-fluorouracil antitumor activity by leucovorin in vivo. (1989) (45)
- Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents. (1989) (45)
- Cytogenetic studies in 45 patients with acute lymphocytic leukemia. (1969) (45)
- Clinical studies of dichloromethotrexate (NSC 29630) (1965) (43)
- Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance. (1985) (43)
- Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. (1991) (41)
- A comparative study of the effect of transfusion of fresh and preserved whole blood on bleeding in patients with acute leukemia. (1959) (41)
- Clinical studies with tumour necrosis factor. (2007) (40)
- RECENT ADVANCES IN ACUTE LEUKEMIA. (1964) (40)
- Clinical studies of vinblastine. (1961) (39)
- Intrathecal aminopterin therapy of meningeal leukemia. (1963) (38)
- Renal and hepatic enlargement in acute leukemia (1963) (37)
- Clinical Studies of 6-Azauracil (1960) (37)
- Announcement of formation of: The lymphoma task force and pathology reference center (1968) (37)
- Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma. (1977) (37)
- Distribution of purine ribonucleoside kinase and selective toxicity of 6-methyl thiopurine ribonucleoside. (1968) (36)
- The crisis in clinical cancer research. Third-party insurance and investigational therapy. (1988) (36)
- Chemotherapy of acute leukemia (1964) (36)
- Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma. (1972) (35)
- 5 – Resistance to Alkylating Agents: Basic Studies and Therapeutic Implications (1988) (34)
- Correlations of the biochemical and clinical effects of 6-azauridine in patients with leukemia (1962) (34)
- Hemodialysis and enzymatic cleavage of methotrexate in man. (1978) (34)
- A clinical pharmacologic study of chemotherapy and x-ray therapy in lung cancer. (1967) (33)
- Clinical trials with N‐isopropyl‐α‐(2‐methylhydrazino)‐p‐toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia (1967) (33)
- Thymidine requirements for the rescue of patients treated with high-dose methotrexate. (1980) (33)
- The effect of actinomycin D on childhood neoplasms. (1960) (33)
- Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy. (1987) (33)
- THE EFFECT OF TREATMENT IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA. BIOCHEMICAL STUDIES. (1963) (33)
- Comparative effects of the antitumor agents 5-(Dimethyltriazeno)-imidazole-4-carboxamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on cell cycle of L1210 leukemia cells in vivo. (1970) (32)
- 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma. (1972) (32)
- Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors. (1973) (32)
- Definition of cure for Hodgkin's disease. (1971) (31)
- Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo (2004) (30)
- Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexate. (1979) (30)
- Chemotherapy in pancreatic carcinoma: 5 fluorouracil (5FU) and 1,3 bis-(2 chloretjyl)-1-nitrosourea (BCNU). (1974) (30)
- Hematology : principles and practice (1972) (29)
- BCG Stimulation of Immune Responsiveness in Patients with Malignant Melanoma (1974) (29)
- Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies (2004) (29)
- Electroencephalographic and neurological changes induced in man by the administration of 1, 2,4-triazine-3,5 (2H, 4H)-dione (6-azauracil). (1957) (29)
- Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro. (1977) (28)
- SQM1 Antiody defines a surface membrane antigen in squamous carcinoma of the head and neck (1985) (28)
- Chemoresistance in rat ovarian tumours. (1991) (27)
- COMPARATIVE TRIAL OF CHEMOTHERAPY AND RADIOTHERAPY IN PATIENTS WITH NON-RESECTABLE CANCER OF THE LUNG. (1963) (27)
- Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine. (1971) (26)
- Acute in vivo resistance in high-dose therapy. (1998) (26)
- Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro (2004) (26)
- Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II). (1987) (25)
- STUDIES OF THE PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (1964) (25)
- Methotrexate analogues. 25. Chemical and biological studies on the gamma-tert-butyl esters of methotrexate and aminopterin. (1985) (25)
- Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination. (1990) (25)
- THE EFFECT OF TREATMENT IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA. HEMATOLOGIC AND CYTOGENETIC STUDIES. (1963) (24)
- Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary report. (1976) (24)
- Determination of intracellular reduced glutathione and glutathione related enzyme activities in cisplatin-sensitive and resistant experimental ovarian carcinoma cell lines. (1989) (24)
- Phase II study of concurrent methotrexate and bleomycin chemotherapy. (1974) (24)
- A Concise History of the Cancer and Leukemia Group B (2006) (23)
- What's in a name--neoadjuvant. (1988) (23)
- Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma (2013) (23)
- Training program in medical oncology. (1973) (23)
- Thymidine arrest and synchrony of cellular growth in vivo. (1980) (22)
- The mechanism of induction of complete remission in acute myeloblastic leukemia in man. (1969) (22)
- Perfluorochemical emulsions: oxygen breathing in radiation sensitization and chemotherapy modulation. (1992) (21)
- Clinical and cytokinetic aspects of remission induction of childhood acute lymphoblastic leukemia (ALL): addition of an anthracycline to vincristine and prednisone. (1977) (21)
- Remission Induction in Adults with Acute Myelogenous Leukemia (1970) (21)
- Adjuvant chemotherapy for osteosarcoma: a decade of experience. (1981) (21)
- Cell cycle synchronization of human lymphoid cells in vitro by 2,3-dihydro-1h-imidazo[1,2-b]pyrazole. (1976) (20)
- General Motors Cancer Research Foundation prizes Charles F. Kettering prize. Acute leukemia in children. Model for the development of scientific methodology for clinical therapeutic research in cancer (1984) (20)
- SECONDARY ASPERGILLOSIS. (1964) (20)
- Rationale for combined therapy (1977) (20)
- Evaluation of a new chemotherapeutic agent in patients with 'advanced refractory' acute leukemia. Studies of 6-azauracil. (1960) (19)
- Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma. (1991) (19)
- The clinical use of actinomycin. (1974) (19)
- Induction chemotherapy as initial treatment for advanced head and neck cancer: a model for the multidisciplinary treatment of solid tumors. (1987) (19)
- Diverse prognosis in metastatic breast cancer: Who should be offered alternative initial therapies? (2005) (18)
- Gene deletion: a new target for cancer chemotherapy (1993) (18)
- Predictive tests for cancer chemotherapy. (1978) (18)
- Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia. (1975) (18)
- Analysis of 4-hydroxycyclophosphamide in human blood. (1995) (18)
- Metabolism of methotrexate and gamma-tert-butyl methotrexate by human leukemic cells in culture and by hepatic aldehyde oxidase in vitro. (1987) (17)
- High-dose chemotherapy with bone marrow support for solid tumors. (1987) (17)
- Pharmacological studies of the antitumor agent 6-methylthiopurine ribonucleoside. (1970) (16)
- Pharmacokinetics of actinoymcin D in patients with malignant melanoma. (1975) (16)
- A Phase 1 study of high doses of aminopterin with leucovorin rescue in patients with advanced metastatic tumors. (1979) (16)
- Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells. (1996) (15)
- FEVER IN MALIGNANT NEOPLASTIC DISEASE: A CONTROLLED STUDY OF TETRACYCLINE THERAPY (1960) (15)
- Status and perspectives in chemotherapy of Hodgkin's disease. (1973) (14)
- Development of alkylating agent-resistant human tumor cell lines (2004) (14)
- Oncology Nurse (2003) (13)
- Transport of a fluorescent antifolate by methotrexate-sensitive and methotrexate-resistant human leukemic lymphoblasts. (1986) (13)
- Cancers of unknown origin: current approaches and future perspectives. (1982) (13)
- Treatment of meningeal leukemia with intrathecal aminopterin. (1962) (13)
- COMPARATIVE CLINICAL TOXICITY OF 6-MERCAPTOPURINE (NSC-755)-1 AND 6-MERCAPTOPURINE RIBONUCLEOSIDE (NSC-4911)-2 ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH ADVANCED CANCER. (1964) (12)
- A comparative study of optimal medical care with and without azaserine in multiple myeloma (1961) (12)
- Cellular uptake of purine antimetabolites in vitro. I. Uptake of 6-methylthiopurine ribonucleoside by human erythrocytes. (1969) (12)
- The Systemic Approach to Cancer Therapy (1967) (11)
- STUDIES ON MURINE AND HUMAN LEUKEMIA. (1964) (11)
- Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanoma. (1971) (11)
- THE EFFECT OF 6-AZAURIDINE ADMINISTRATION ON DE NOVO PYRIMIDINE PRODUCTION IN CHRONIC MYELOGENOUS LEUKEMIA. (1964) (11)
- A comparative study of 9α‐bromch‐11β ketoprogesterone and prednisolone in the treatment of advanced carcinoma of the female breast (1963) (10)
- Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype. (1998) (10)
- Modulation of alkylating agents by lonidamine in vivo. (1991) (10)
- Prospectus for cancer chemotherapy. (1972) (10)
- Principles of Oncology Nursing (2000) (9)
- Phase I. evaluation of cyclocytidine (NSC-145668). (1975) (9)
- Flow cytometric studies of methotrexate resistance in human squamous carcinoma cell cultures. (1987) (9)
- Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule. (1973) (9)
- Combinations of arabinosyl cytosine and 6-thioguanine for treatment of adults with acute leukemia. (1975) (9)
- Methotrexate and gamma-tert-butyl methotrexate transport in CEM and CEM/MTX human leukemic lymphoblasts. (1993) (9)
- The effectiveness of pyrazolo[3,4‐d] pyrimidines against transplantable mouse tumors (1960) (9)
- New agents and combinations in the treatment of bronchogenic carcinoma. (1973) (8)
- 1,3 Bis‐(2 chloroethyl)‐1‐nitrosourea and streptozotocin chemotherapy (1975) (8)
- SQM1 antibody defines a surface membrane antigen in squamous carcinoma of the head and neck. (1985) (8)
- Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy. (1973) (8)
- Principles of Cancer Rehabilitation Medicine (2000) (8)
- The feasibility of using randomization schemes early in the clinical trials of new chemotherapeutic agents: Hydroxyurea (NSC‐32065) (1965) (8)
- METHOTREXATE‐THYMIDINE TREATMENT OF MURINE LEUKEMIA * (1975) (8)
- MEHTYL-5-FLUOROOROTATE: SYNTHESIS AND COMPARISON WITH 5-FLUOROOROTIC ACID WITH RESPECT TO BIOLOGICAL ACTIVITY AND CELL ENTRY. (1964) (8)
- METHOTREXATE ANALOGS. 25. CHEMICAL AND BIOLOGICAL STUDIES ON THE Γ-TERT-BUTYL ESTERS OF METHOTREXATE AND AMINOPTERIN (1985) (8)
- Editorial: Cancer research-controversy, progress and prospects. (1975) (7)
- Immunological and cytogenetic studies in two cases of B-cell acute lymphoblastic leukemia (Burkitt's type). (1983) (7)
- BREAST CANCER: COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH. (1965) (7)
- Letter: Therapy for Hodgkin's disease. (1974) (6)
- Combination of etanidazole with cyclophosphamide and platinum complexes (2004) (6)
- Distribution and mechanism of clearance of L-asparaginase (NSC-109229). (1971) (6)
- Immunohistochemical identification of squamous carcinoma of the head and neck with monoclonal antibody SQM1. (1986) (6)
- Adriamycin plus alkylating agents in the treatment of metastatic breast cancer (1977) (6)
- Pharmacokinetics of dibromodulcitol in humans: a phase I study. (1986) (6)
- Combination Chemotherapy (1974) (6)
- New approaches to the treatment of non-Hodgkin's lymphoma. (1977) (6)
- Combination Chemotherapy: Clinical Considerations (1974) (5)
- A comparison of the efficacy of tetracycline and penicillin in the treatment of pneumococcal pneumonia. (1955) (5)
- Cytokinetic studies and treatment response in adult acute leukemia. (1973) (5)
- Intensive post-remission therapy with Ara-C in adults with acute myeloid leukemia: initial results of a CALGB phase III trial. The Cancer and Leukemia Group B. (1992) (5)
- Letter: Limitations of methotrexate and citrovorum-factor treatments. (1975) (5)
- Multidisciplinary treatment for cancer--new opportunities. (1982) (5)
- Cancer chemotherapy (1983) (5)
- Therapeutic innovation: the up-front window. (1998) (4)
- 5-Fluorouracil treatment of a human colon adenocarcinoma implanted in the subrenal capsule site of athymic mice. (1986) (4)
- A commentary. Selected considerations regarding chemotherapy as adjuvant in cancer treatment. (1966) (4)
- Acute granulocytic leukemia in adults. (1972) (4)
- 6-THIOGUANINE (NSC-752)-1 THERAPY IN PATIENTS WITH MULTIPLE MYELOMA. (1964) (4)
- Perspectives in cancer prevention (1990) (4)
- Principles of Bone Marrow Transplantation (2000) (3)
- Antitumor agents--dose response curve clinical and experimental considerations. (1979) (3)
- Pharmacologic and cytokinetic studies of arabinosyl cytosine. (1973) (3)
- VAPA10: a treatment program for acute myelocytic leukemia. (1981) (3)
- Recent advances in the treatment of primary brain tumors. A seminar. (1975) (3)
- Re: Position paper on curative cancer chemotherapy. (1987) (3)
- Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma (2004) (3)
- Long-term persistence and cytokinetics of human tumor cells in vitro following high-dose alkylating agent exposure. (1994) (3)
- CHEMOIMMUNOTHERAPY – STRATEGY CONSIDERATIONS (1985) (3)
- Phase I and phototoxicity studies of pseudourea (NSC-56054). (1971) (3)
- Advances in the chemotherapy of acute leukemia. (1970) (3)
- INTENSIVE POST-REMISSION INDUCTION CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN CHILDREN AND ADULTS (1984) (3)
- Clinical Trials with Tumor Necrosis Factor (1990) (3)
- The Future of Cancer Control (1978) (3)
- Combination chemotherapy of acute leukemia and Hodgkin's disease. (1972) (2)
- Studies on the biological action of adriamycin analog, N tri fluoroacetyl adriamycin (AD-32) (1977) (2)
- Section 31: The Breast (2003) (2)
- C. GORDON ZUBROD, MD (1999) (2)
- The treatment of acute myelogenous leukemia in children and adults: VAPA update. (1983) (2)
- The Oncology Pharmacist (2003) (2)
- The Rehabilitation Specialist (2003) (2)
- Symposium on Hodgkin's Disease (1973) (2)
- Strategies for Increasing the Efficacy of and Overcoming Resistance to Platinum Complexes In Vivo (1991) (2)
- Possible role of cell kinetics in prediction of the response to cancer therapy. (1971) (2)
- A preclinical model for sequential high-dose chemotherapy (2004) (2)
- Adjuvant and Neoadjuvant Chemotherapy (2003) (2)
- Clinical Trial of the Cytostatic Agent A-139 (2,5-Bis[1-Aziridinyl]-3,6-bis[2-methoxyethoxy]-p-benzoquinone) (1960) (2)
- Advances in Cancer Chemotherapy (1976) (2)
- Drug Resistance In The Treatment of Cancer: Resistance to antitumor alkylating agents and cisplatin (1998) (2)
- Modulation of antitumor alkylating agents (AA). (1991) (2)
- Principles of Cancer Pathology (2000) (2)
- Some thoughts on adjuvant cancer chemotherapy (1967) (2)
- Selman A. Waksman Conference on actinomycins: their potential for cancer chemotherapy. Preface. (1974) (2)
- Chemotherapy of childhood tumors. (1960) (1)
- Intensified Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia: An Update of CALGB 8525 (1997) (1)
- Book ReviewCancer Biology (1982) (1)
- A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients (2004) (1)
- Methotrexate revisited. (1976) (1)
- Prognotic significance of pretreatment proliferative activity in adult acute leukemia. (1977) (1)
- Cancer medicine : review : a companion to Holland-Frei (2000) (1)
- Myron r. karon--a tribute. (1975) (1)
- Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo (1990) (1)
- Symposium on immunosuppressive drugs. Effect of cancer chemotherapeutic agents on normal tissues in man. (1967) (1)
- Medical Oncologist (2003) (1)
- Comprar Holland-Frei Cancer Medicine 8th | Waun Ki Hong | 9781607950141 | Mcgraw-Hill Education (2010) (1)
- Summary of Informal Discussion on Clinical Obstacles to the Control of Leukemia (1965) (1)
- Twenty years and a day with Frank Schabel (1984) (1)
- Section 23: Central Nervous System (2003) (1)
- Resolution on cancer. (1971) (1)
- Section 3: Cancer Etiology (2003) (1)
- Summary and prospective statement concerning the genitourinary workshop. (1981) (1)
- Section 1: Cancer Biology (2003) (1)
- Toxic epidermal necrolysis resembling erythema multiforme. (1968) (1)
- PhenotypicHeterogeneityin Cultured HumanHeadand Neck SquamousCell CarcinomaLines with Low-Level MethotrexateResistance1 (1985) (1)
- Treatment of acute leukemia. (1972) (1)
- Cancer medicine - 6 review (2013) (1)
- What is a surgical oncologist? (2006) (1)
- Studiesof a patient isolator unit and prophylactic antibiotics in cancer chemotherapy. General techniques and preliminary results. (1968) (1)
- THE STATHMOKINETIC EFFECT OF VINCRISTIME. (1964) (1)
- Section 34: Hematopoietic System (2003) (1)
- Schedule of Drug Administration (2003) (0)
- Section 12: Chemotherapeutic Agents (2003) (0)
- The Regulation of proliferation and differentiation in normal and neoplastic cells (1989) (0)
- Neo-Adjuvant chemotherapy: new approaches involving alkylating agent modulation (1991) (0)
- Cancer congress in Argentina. (1977) (0)
- Section 5: Clinical Trials and Outcomes Assessment (2003) (0)
- Clonogenic assays: production and use of monoclonal antibodies to obtain a selective assay system. Abstr. (1982) (0)
- The Psycho-oncologist (2003) (0)
- A lesson from Canada: Ontario's health insurance. (1978) (0)
- Fundamental Science, Clinical Science, and Medical Art (2003) (0)
- The Pediatric Oncologist (2003) (0)
- A Phase 1 Study of High Doses of Aminopterin with Leucovorin Rescue in Patients with Advanced Metastatic Tumors 1 (2006) (0)
- The evolution of curative cancer therapy. (1992) (0)
- Cancer update : current topics in research : based on an international educational seminar held in Tokyo on July 15-16, 1989 (1990) (0)
- Section 9: Radiation Oncology (2003) (0)
- The Primary Physician (2003) (0)
- Nomenclature: Systeme Internationale (SI) Units (2003) (0)
- Comparisons of activities of antitumor agents in selected human and rodent tumor systems. (1962) (0)
- Section 32: The Skin (2003) (0)
- Part IX Informatics (2003) (0)
- The Phase III Cancer Clinical Trial (1997) (0)
- Part VII Pediatric Oncology (2003) (0)
- BJ Kennedy, M.D. (2003) (0)
- 39. Lengths of Remissions for Children with Acute Leukemia (1985) (0)
- Section 37: Pediatric Oncology (2003) (0)
- Cancer chemotherapy. (1983) (0)
- Proceedings of the Symposium on Cell Kinetics and Cancer Chemotherapy (Annapolis, Maryland, November 4-6, 1975): Introduction to session on drug scheduling--clinical studies. (1976) (0)
- Part II Scientific Foundation (2003) (0)
- How Basic Knowledge of the Cell Cycle Has Helped Us Treat Cancer Patients (1979) (0)
- Part V Multidisciplinary Management (2003) (0)
- Principles of Endocrine Therapy (2000) (0)
- Progress in the chemotherapy of hematologic diseases. (1975) (0)
- Section 36: Unknown Primary Site (2003) (0)
- Section 39: Infection in the Cancer Patient (2003) (0)
- Book ReviewCell Kinetics and Cancer Therapy (1982) (0)
- The Radiation Oncologist (2003) (0)
- The treatment of leukemia. (1958) (0)
- Section 17: Psycho-Oncology (2003) (0)
- Section 27: The Thorax (2003) (0)
- Updated Hodgkins' disease. C. Advanced disease and special problems. Advances in chemotherapy. (1973) (0)
- Section 24: The Eye (2003) (0)
- Figure 40.1, [Log kill in vitro: effect...]. (2000) (0)
- Section 7: Imaging (2003) (0)
- Section 14: Endocrine Therapy (2003) (0)
- Section 20: Multidisciplinary Management (2003) (0)
- To the editor (2006) (0)
- Section 16: Bone Marrow Transplantation (2003) (0)
- Curative Cancer Chemotherapy 1 (2006) (0)
- The Expanding Role of Medical Oncology in Genitourinary Cancer (1983) (0)
- Selective Incorporation of i_-3,4-Dihydroxyphenylalanme by S-91 Cloudman Melanoma in Wfro1 (2006) (0)
- Cancer Congress in Argentina (1977) (0)
- Leucovorin lv increases 5 10 methylenetetrahydrofolate mtf in vivo (1988) (0)
- Current status and new vistas in combination chemotherapy. (1985) (0)
- Section 13: Biotherapeutics (2003) (0)
- Combinationof A^A^A^'-Triethylenethiophosphoramide and Cyclophosphamide i/i Vitro and in Vivo1 (1988) (0)
- Section 10: Medical Oncology (2003) (0)
- Section 35: Neoplasms in Aids (2003) (0)
- the Normal and Leukemic HumanBone Marrow (1970) (0)
- Section 30: Female Reproductive Organs (2003) (0)
- Experimental Design and Clinical Cancer Chemotherapy (1967) (0)
- Part VI Cancer Management (2003) (0)
- BCG and Lymphoma (1974) (0)
- Intramural therapeutic research at the National Cancer Institute, Department of Medicine: 1955-1965. (1984) (0)
- ThymidineRequirements for the Rescueof PatientsTreatedwith High-DoseMethotrexat& (1980) (0)
- Section 18: Oncology Nursing (2003) (0)
- The treatment of leukemia. (1958) (0)
- Acute lymphatic leukemia (1973) (0)
- Section 21: Pain and Palliation (2003) (0)
- When the Students Are Away... (1999) (0)
- Resolution on Cancer (1971) (0)
- Comprar Holland Frei Cancer Medicine Review | Emil Frei, III | 9781550093094 | BC Decker (2007) (0)
- Curative Cancer Chemotherapy1 (2006) (0)
- Chemotherapy in Pancreatic Carcinoma (1974) (0)
- 3rd Indo-German Workshop on Recent Results in Cooperative Cancer Research (2005) (0)
- Editorial: BCG and lymphoma. (1974) (0)
- Alkylating Dose Preclinical Studies and Clinical Correlation of the Effect of Updated Version (2006) (0)
- Part VIII Complications (2003) (0)
- Section 2: Cancer Immunology (2003) (0)
- Section 11: Chemotherapy (2003) (0)
- Laws of Therapeutics (2003) (0)
- Section 25: Endocrine Glands (2003) (0)
- The curative treatment of lymphoma. (1970) (0)
- Curing leukemia. (1991) (0)
- Section 15: Gene Therapy (2003) (0)
- Neoplasms of the Eye (2000) (0)
- Surrogate End Points (2003) (0)
- Theory and Practice of Clinical Trials (2000) (0)
- Section 28: Gastrointestinal Tract (2003) (0)
- Section 6: Cancer Pathology (2003) (0)
- Part III Cancer Diagnosis (2003) (0)
- Section 38: Complications of Cancer and its Treatment (2003) (0)
- Part IV Therapeutic Modalities (2003) (0)
- Combination Chemotherapy in Advanced Hodgkin's Disease (2020) (0)
- The effectiveness of 2-amino-6-[(1-methyl-4-nitro-5-imidazolyl)thio] purine against transplantable mouse leukemia. (1960) (0)
- Advances in Chemotherapy (1973) (0)
- Section 26: Head and Neck (2003) (0)
- Informal discussion: experimental basis for the chemical eradication of leukemia. (1967) (0)
- Principles of Multidisciplinary Management (2003) (0)
- A symposium on cancer chemotherapy. III. Solid tumors. (1962) (0)
- Section 29: Genitourinary Tract (2003) (0)
- Section 41: Oncology and Informatics (2003) (0)
- Dose Schedule and Antitumor Studies of Arabinosyl Cytosine ( NSC 6387 S ) 6 7 Writing Committee (2006) (0)
- Section 19: Cancer Rehabilitation Medicine (2003) (0)
- Pharmacologic Studies of the Antitumor Agent 5-( Dimethyltriaz 1 @ 2 (2006) (0)
- Section 40: Oncologic Emergencies (2003) (0)
- BONE CANCER TREATED BY DRUG RESCUE METHOD (1974) (0)
- Progress and Perspectives in the Chemotherapy of Epithelial Solid Tumors (1999) (0)
- Medical Oncologist's Role (2003) (0)
- Section 8: Surgical Oncology (2003) (0)
- - Diamminedichloroplatinum ( II ) cis and Neck Carcinoma Cells Selected for Resistance to Collateral Methotrexate Resistance in Cultured Human Head (2006) (0)
- Section 22: Societal Oncology (2003) (0)
- Comparisonof Pharmacokineticsof 5-Fluorouraciland 5-Fluorouracil with ConcurrentThymidine Infusionsin a Phase I Trial1 (1980) (0)
- Refractory" Acute Leukemia. Studies of 6-Azauracil Evaluation of a New Chemotherapeutic Agent in Patients with "Advanced (2011) (0)
- Part I Cardinal Manifestations (2003) (0)
- Section 33: Bone And Soft Tissue (2003) (0)
- Gynecologic Oncologist (2003) (0)
- Section 4: Cancer Epidemiology, Prevention, and Screening (2003) (0)
This paper list is powered by the following services:
